Brief: Orbimed Advisors Reports A Stake Of 8.9% In BELLUS Health As Of Sept. 9
Sept 18 (Reuters) -
* ORBIMED ADVISORS REPORTS A STAKE OF 8.9% IN BELLUS HEALTH
AS OF
SEPT. 9 - SEC FILING
Source: http://bit.ly/2moQcVf
Further company coverage: BLU.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BELLUS Health
See all newsBrief: Bellus Health Inc. Calls Special Shareholders’ Meeting In Connection With Gsk Acquisition
Brief: Bellus Health Reports First Quarter 2023 Financial Results And Business Highlights
Press Digest: British Business - April 19
Canada Stocks: Toronto market extends winning streak on 'soft landing' hopes
Bellus soars as GSK plans to buy drug developer for $2 bln